Background: Interval carcinoma is defined as a carcinoma detected betw
een two mammographic screening rounds after a negative screening. By s
ome authors these carcinomas are considered to be more aggressive than
screen-detected carcinomas. Methods: In a group of 937 patients refer
red for breast cancer in the period 1975-1990, 76 interval carcinoma p
atients were treated. In a retrospective study the outcome was studied
of patients with an interval carcinoma in comparison with patients wi
th screen-detected carcinomas and of patients with clinically detected
carcinomas outside the screening program. Results: No significant dif
ference was found in the 5-year and 10-year disease-free survival of p
atients with interval carcinoma (80%, 68%) and the screen-detected gro
up (89%, 81%) (P = 0.12). The interval group did significantly better
than the patients with carcinomas detected outside the screening progr
am (P = 0.03). Conclusion: Interval-detected cancers for patients in t
he screening program had an outcome intermediate between patients with
screen-detected cancers and patients with cancers detected outside th
e screening program. The difference between interval-detected cancers
and cancers detected outside the screening program was significant, wh
ereas the difference between screen-detected and interval cancers was
not. (C) 1996 Wiley-Liss, Inc.